Cargando…

Cardio-oncology in 2022

Detalles Bibliográficos
Autor principal:	Dobson, Rebecca
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Radcliffe Cardiology 2023
Materias:	Cardio-Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10345983/ https://www.ncbi.nlm.nih.gov/pubmed/37456774 http://dx.doi.org/10.15420/ecr.2022.45

Ejemplares similares

The 2022 European Society of Cardiology Cardio-oncology Guidelines in Focus
por: Gent, David G, et al.
Publicado: (2023)

Cardiac Computed Tomography in Cardio-Oncology: JACC: CardioOncology Primer
por: Lopez-Mattei, Juan C., et al.
Publicado: (2021)

Strain Imaging in Cardio-Oncology
por: Liu, Jennifer E., et al.
Publicado: (2020)

Cardio‐Oncology at the Beginning of a New Decade
por: Grumbach, Isabella M.
Publicado: (2020)

Permissive Cardiotoxicity: The Clinical Crucible of Cardio-Oncology
por: Porter, Charles, et al.
Publicado: (2022)

Primer on Biomarker Discovery in Cardio-Oncology: Application of Omics Technologies
por: Rhee, June-Wha, et al.
Publicado: (2020)

Reverse Cardio‐Oncology: Cancer Development in Patients With Cardiovascular Disease
por: Aboumsallem, Joseph Pierre, et al.
Publicado: (2020)

Racial and Ethnic Disparities in Cardio-Oncology: A Call to Action
por: Fazal, Muhammad, et al.
Publicado: (2021)

Cardiotoxicity of T-Cell Antineoplastic Therapies: JACC: CardioOncology Primer
por: Ganatra, Sarju, et al.
Publicado: (2022)

Cardioprotection in Patients at High Risk of Anthracycline-Induced Cardiotoxicity: JACC: CardioOncology Primer
por: Henriksen, Peter A., et al.
Publicado: (2023)

The Evolving Immunotherapy Landscape and the Epidemiology, Diagnosis, and Management of Cardiotoxicity: JACC: CardioOncology Primer
por: Zhang, Lili, et al.
Publicado: (2021)

Cardiac Magnetic Resonance in Cardio-Oncology: Advantages, Importance of Expediency, and Considerations to Navigate Pre-Authorization
por: O’Quinn, Rupal, et al.
Publicado: (2021)

Developing a Model for Cross-Institutional Educational Collaborations: The Chicago Cardio-Oncology Consortium (CCC) Experience
por: Minga, Iva, et al.
Publicado: (2023)

Potential Applications for Targeted Gene Therapy to Protect Against Anthracycline Cardiotoxicity: JACC: CardioOncology Primer
por: Kok, Cindy Y., et al.
Publicado: (2021)

Dyspnoea in Oncological Patients: A Brain Teaser
por: Keramida, Kalliopi, et al.
Publicado: (2023)

Cardio-oncology Training in the COVID-19 Era
por: Feldman, Stephanie, et al.
Publicado: (2021)

Cardio-oncology: Shared Genetic, Metabolic, and Pharmacologic Mechanism
por: Zhao, Yiqi, et al.
Publicado: (2023)

Disparities in Cardio-oncology: Effects On Outcomes and Opportunities for Improvement
por: Ahmad, Javaria, et al.
Publicado: (2022)

The COVID-19 Pandemic and its Impact on the Cardio-Oncology Population
por: Asokan, Ishan, et al.
Publicado: (2020)

Reaching Across the Aisle: Cardio-Oncology Advocacy and Program Building
por: Sadler, Diego, et al.
Publicado: (2021)

Strategies for Cardio-Oncology Care During the COVID-19 Pandemic
por: Abraham, Sonu, et al.
Publicado: (2022)

Innovations in Cardio-oncology Resulting from the COVID-19 Pandemic
por: Kondapalli, Lavanya, et al.
Publicado: (2022)

Recent Advances in Serum Biomarkers for Risk Stratification and Patient Management in Cardio-Oncology
por: Joolharzadeh, Pouya, et al.
Publicado: (2023)

The Role and Impact of Social Media in Cardio-oncology During the COVID-19 Pandemic
por: Kwan, Jennifer M., et al.
Publicado: (2021)

How to Treat Diffuse Large B-Cell Lymphoma: Oncologic and Cardiovascular Considerations
por: Kambhampati, Swetha, et al.
Publicado: (2023)

Mitochondrial Dynamin-Related Protein Drp1: a New Player in Cardio-oncology
por: Deng, Yali, et al.
Publicado: (2022)

Cancer and Postradiotherapy Cardiotoxicity: How to Face Damage in Women’s Hearts?
por: Peix, Amalia, et al.
Publicado: (2023)

Increased resting heart rate and prognosis in treatment‐naïve unselected cancer patients: results from a prospective observational study
por: Anker, Markus S., et al.
Publicado: (2020)

Long‐term survivors of early breast cancer treated with chemotherapy are characterized by a pro‐inflammatory biomarker profile compared to matched controls
por: Tromp, Jasper, et al.
Publicado: (2020)

Common mechanistic pathways in cancer and heart failure. A scientific roadmap on behalf of the Translational Research Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)
por: de Boer, Rudolf A., et al.
Publicado: (2020)

Palpitations in the Cancer Patient
por: Essa, Hani, et al.
Publicado: (2021)

Chest Pain in the Cancer Patient
por: Tyebally, Sara, et al.
Publicado: (2022)

Modeling Precision Cardio-Oncology: Using Human-Induced Pluripotent Stem Cells for Risk Stratification and Prevention
por: Perry, Tatiana R., et al.
Publicado: (2021)

LVEF by Multigated Acquisition Scan Compared to Other Imaging Modalities in Cardio-Oncology: a Systematic Review
por: Printezi, Markella I., et al.
Publicado: (2022)

Cardiovascular Disease in Adult Cancer Survivors: a Review of Current Evidence, Strategies for Prevention and Management, and Future Directions for Cardio-oncology
por: Muhandiramge, Jaidyn, et al.
Publicado: (2022)

The ESC 2022 Cardio-Oncology Guidelines and the Road Ahead in Cardio-Oncology
por: Cheng, Richard K., et al.
Publicado: (2022)

Type 4 hiatal hernia causing haemodynamic compromise by compression of the left atria
por: Tynas, Rebecca, et al.
Publicado: (2020)

Changes in Cardiovascular Biomarkers With Breast Cancer Therapy and Associations With Cardiac Dysfunction
por: Demissei, Biniyam G., et al.
Publicado: (2020)

Heart failure after treatment for breast cancer
por: Boekel, Naomi B., et al.
Publicado: (2019)

Myocardial dysfunction in long‐term breast cancer survivors treated at ages 40–50 years
por: Jacobse, Judy N., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_q35enusc68t0tc4h1oku362sir